SCHEMBL13017398

SCHEMBL13017398

Cc1ccc(CC(=O)N=O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTBP2 P56545 1/20 0.53
RAB9A P51151 4/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
NPC1 O15118 3/20 0.47
HPGD P15428 4/20 0.46
TDP1 Q9NUW8 1/20 0.46
KMT2A Q03164 5/20 0.43
MEN1 O00255 4/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
ALDH1A1 P00352 2/20 0.43
GAA P10253 1/20 0.43
LMNA P02545 1/20 0.43
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9942257 0.83 ALDH1A1 (0.48) RAB9AHPGDTDP1KMT2AMEN1
SCHEMBL14997451 0.80 CA2 (0.58) HPGDTDP1KMT2AMEN1ALDH1A1
SCHEMBL24653097 0.79 L3MBTL1 (0.51) CTBP2RAB9AL3MBTL1NPC1TDP1
SCHEMBL17040103 0.78 GFER (0.42) RAB9ATDP1ALDH1A1MAPTCNR2
SCHEMBL13272365 0.78 ALDH1A1 (0.40) CTBP2TDP1KMT2AALDH1A1GAA
SCHEMBL15372403 0.78 CES2 (0.44) CTBP2ALDH1A1GAALMNA
SCHEMBL13741321 0.78 CTBP2 (0.53) CTBP2RAB9AL3MBTL1NPC1HPGD
SCHEMBL13272118 0.78 HTT (0.59) CTBP2NPC1TDP1SMN1; SMN2ALDH1A1
SCHEMBL7832793 0.77 CES1 (0.58) CTBP2L3MBTL1KMT2AMEN1ALDH1A1
SCHEMBL4940818 0.77 L3MBTL1 (0.62) CTBP2RAB9AL3MBTL1NPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2258366-A2 Quinoline derivatives and quinazoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same Kirin Pharma Kabushiki Kaisha (JP) 2010-12-08 EP disclosed
EP-1411046-B1 QUINOLINE DERIVATIVE AND QUINAZOLINE DERIVATIVE INHIBITING SELF-PHOSPHORYLATION OF HEPATOCYTUS PROLIFERATOR RECEPTOR, AND MEDICINAL COMPOSITION CONTAINING THE SAME KIRIN PHARMA KK (JP) 2009-09-16 EP disclosed
WO-2007000550-A2 NOVEL INDOLINE COMPOUNDS LABORATOIRES FOURNIER S.A. (FR) 2007-01-04 WO disclosed